Detalhe da pesquisa
1.
Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 118(4): 590-7, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26780387
2.
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
Eur Urol
; 80(6): 746-757, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785256
3.
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response.
Clin Cancer Res
; 27(2): 429-437, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023952
4.
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer.
J Immunother Cancer
; 8(1)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269146
5.
A case report of multiple primary prostate tumors with differential drug sensitivity.
Nat Commun
; 11(1): 837, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054861
6.
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer.
Transl Lung Cancer Res
; 8(3): 247-257, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367538
7.
EGFR Mutations in Latinos From the United States and Latin America.
J Glob Oncol
; 2(5): 259-267, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717712
8.
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors.
Oncotarget
; 5(18): 8161-72, 2014 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25327558